VIVO

Meridian Bioscience Inc (VIVO) | Rumor.io

Meridian Bioscience

VIVO

Attention (50-day avg)0%

Attention rank (50-day avg)#2,529

Bullish sentiment (50-day avg)65%

Price to earnings ratio35.4

Market capitalization126.1M

Earnings per share-2.17

Dividend yield (TTM)—

Revenue (annual)16K

Net income (annual)-46.7M

Social

What share of all stock conversation is about VIVO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% +0

Aug 17

The company is planning to raise capital through a separate AI Infrastructure Platform, which will allow it to eliminate future construction funding requirements and retain de facto control and economic exposure.
The CEO's announcement of a tenant for the Nordic assets is highly anticipated, with key milestones including a tenant announcement, pre-IPO funding round, and platform valuation.
The company's valuation and potential listing on the London Stock Exchange (LSE) or Abu Dhabi Stock Exchange (ADX) are expected to unlock value for the company.

Generated by AI

Sentiment

Of the messages about VIVO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0% 0	0% 0	53.85% -15.51	91.01% -8.99
Bearish	100% 0	100% 0	46.15% +15.51	8.99% new

Bullish· Jun 29

The asset has made significant progress with the selection of a global AI industry leader, de-risking the Norway asset and expanding talks to the full pipeline, which is a solid step up from the May 21 shortlist update.
The company is expected to announce a major deal, which will likely lead to a significant increase in the asset's value, with some predicting a x2 or x3 increase in the near term.
The asset has a tight float and high short interest, which sets up a strong potential for a squeeze and a significant price move on further positive updates, with some expecting it to run hard and reach $15-$20 in anticipation of the deal announcement.

Bearish· Jun 18

$VIVO is likely a scam with investors being misled by its promoters, including the company's CEO Kevin Chin.
The stock's high short interest and recent price dumping suggest it may be overvalued and due for a significant decline.
The company's delay in spinning off its Tembo subsidiary and the risk of SEC enforcement on its claims may further weigh on the stock's price.

Generated by AI

Topics

Of the messages about VIVO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	91.75%
Technical Analysis	—	—	0%	6.74%
Earnings	—	—	0%	0.26%
Analysts	—	—	0%	0.03%
Macro	—	—	0%	0.95%
Controversies	—	—	0%	0.26%

Earnings· Jul 31

Meridian Bioscience's EPS was in-line with estimates, but the company missed on revenue in the third quarter.
The company reported FQ3 earnings of 18c EPS and $51.74M Revs, missing the Estimize Revenue Consensus by $0.76M.
Meridian Bioscience guided FY18 EPS and revenue in-line with estimates, but the company's revenue in the third quarter was slightly below estimates.

Announcements· Jun 29

VivoPower has selected a preferred AI tenant for its Mo i Rana data center lease, with the tenant identified as a global AI industry leader, but the name and lease terms are still pending legal documentation.
The selection of a preferred tenant is seen as a positive step, with the Norway asset being de-risked further, and the expansion of talks to the full pipeline being the real long-term value driver for the company.
The announcement has been framed as a target for agreement by June 30, but the company has clarified that this is not a hard contractual deadline, and that the deal may take longer to finalize due to legal and commercial finalization.

Generated by AI

Community

Of the messages about VIVO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	88.89%	76.36%	7.61%
Newcomers	0%	11.11%	23.64%	92.39%

Regulars· Jul 29

The company has secured a $50M strategic PIPE at $7.50/share conversion price, led by Blue Sky Capital, to support the Mo i Rana AI data center conversion in Norway and corporate debt reduction.
Many investors are questioning management's credibility due to the absence of a promised tenant announcement, which has materially weakened their credibility and raised questions about the status of negotiations.
Some investors are shorting the stock, considering it a scam, and believe the recent news is not significant enough to warrant an increase in the stock price, despite the company's efforts to boost its balance sheet for AI data center growth.

Newcomers· Jul 29

Newcomers to the stock are focusing on the recent PIPE financing deal, with some seeing it as a bullish sign, while others are skeptical and concerned about the dilution of shares.
The stock's recent price and the fact that the financing was priced at $7.50, well above the current share price, are being discussed as significant developments for the company.
The CEO's track record and the company's history of generating little revenue and failing to achieve business goals are being questioned, with some investors expressing skepticism and concerns about the company's legitimacy.

Generated by AI

Also Discussed

Investors talking about VIVO also mention

#	Name	Attention
1	QuidelOrtho CorporationQDEL	0%new
2	Syntec Optics Holdings, Inc. Class A Common StockOPTX	0%new
3	OraSure Technologies Inc.OSUR	0%new
4	VivoPower International PLCVVPR	0%new
5	LifeVantage CorporationLFVN	0%new
6	Greenland Technologies Holding Corp. Class AGTEC	0%new
7	Stabilis Solutions Inc.SLNG	0%0
8	FlexShares Morningstar U.S. Market Factor Tilt ETFTILT	0%0
9	First American Financial CorporationFAF	0%0
10	Virtus Seix AAA Private Credit CLO ETFPCLO	0%new

Meridian Bioscience Inc

Technology
Software - Infrastructure

VivoPower PLC, together with its subsidiaries, provides energy solutions for customized and ruggedized fleet applications, battery and microgrids, and solar and critical power technology and services. It operates through Electric Vehicles, Sustainable Energy Solutions, Solar Development, and Digital Assets segments. The Electric Vehicles segment offers ruggedized battery-powered Electric Vehicle (EV) solutions, including conversion kits for fleet owners in the mining, agriculture, energy utility, defense, police, government, public transport, humanitarian, and game safari industries. It also offers ruggedized or customized on-road applications; public utility vehicle electric powertrain conversion kits for the jeepneys; and OEM light utility pickup trucks under the Tembo Tuskers brand name, as well as EV charging solutions for home and commercial applications. The Sustainable Energy Solutions segment engages in the design, evaluation, sale, and implementation of renewable energy infrastructure. The Solar Development segment develops solar projects. The Digital Assets segment engages in digital asset mining activities. It operates in Australia, Canada, the Netherlands, the United Kingdom, the United States, the United Arab Emirates, and the Philippines. The company was formerly known as VivoPower International PLC and changed its name to VivoPower PLC in March 2026. VivoPower PLC was founded in 2014 and is headquartered in London, the United Kingdom.

Website

Location

Blackwell House

London, EC2V 5AE

United Kingdom

Social

What share of all stock conversation is about VIVO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% +0

Aug 17

The company is planning to raise capital through a separate AI Infrastructure Platform, which will allow it to eliminate future construction funding requirements and retain de facto control and economic exposure.
The CEO's announcement of a tenant for the Nordic assets is highly anticipated, with key milestones including a tenant announcement, pre-IPO funding round, and platform valuation.
The company's valuation and potential listing on the London Stock Exchange (LSE) or Abu Dhabi Stock Exchange (ADX) are expected to unlock value for the company.

Generated by AI

Sentiment

Of the messages about VIVO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0% 0	0% 0	53.85% -15.51	91.01% -8.99
Bearish	100% 0	100% 0	46.15% +15.51	8.99% new

Bullish· Jun 29

The asset has made significant progress with the selection of a global AI industry leader, de-risking the Norway asset and expanding talks to the full pipeline, which is a solid step up from the May 21 shortlist update.
The company is expected to announce a major deal, which will likely lead to a significant increase in the asset's value, with some predicting a x2 or x3 increase in the near term.
The asset has a tight float and high short interest, which sets up a strong potential for a squeeze and a significant price move on further positive updates, with some expecting it to run hard and reach $15-$20 in anticipation of the deal announcement.

Bearish· Jun 18

$VIVO is likely a scam with investors being misled by its promoters, including the company's CEO Kevin Chin.
The stock's high short interest and recent price dumping suggest it may be overvalued and due for a significant decline.
The company's delay in spinning off its Tembo subsidiary and the risk of SEC enforcement on its claims may further weigh on the stock's price.

Generated by AI

Topics

Of the messages about VIVO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	91.75%
Technical Analysis	—	—	0%	6.74%
Earnings	—	—	0%	0.26%
Analysts	—	—	0%	0.03%
Macro	—	—	0%	0.95%
Controversies	—	—	0%	0.26%

Earnings· Jul 31

Meridian Bioscience's EPS was in-line with estimates, but the company missed on revenue in the third quarter.
The company reported FQ3 earnings of 18c EPS and $51.74M Revs, missing the Estimize Revenue Consensus by $0.76M.
Meridian Bioscience guided FY18 EPS and revenue in-line with estimates, but the company's revenue in the third quarter was slightly below estimates.

Announcements· Jun 29

VivoPower has selected a preferred AI tenant for its Mo i Rana data center lease, with the tenant identified as a global AI industry leader, but the name and lease terms are still pending legal documentation.
The selection of a preferred tenant is seen as a positive step, with the Norway asset being de-risked further, and the expansion of talks to the full pipeline being the real long-term value driver for the company.
The announcement has been framed as a target for agreement by June 30, but the company has clarified that this is not a hard contractual deadline, and that the deal may take longer to finalize due to legal and commercial finalization.

Generated by AI

Community

Of the messages about VIVO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	88.89%	76.36%	7.61%
Newcomers	0%	11.11%	23.64%	92.39%

Regulars· Jul 29

The company has secured a $50M strategic PIPE at $7.50/share conversion price, led by Blue Sky Capital, to support the Mo i Rana AI data center conversion in Norway and corporate debt reduction.
Many investors are questioning management's credibility due to the absence of a promised tenant announcement, which has materially weakened their credibility and raised questions about the status of negotiations.
Some investors are shorting the stock, considering it a scam, and believe the recent news is not significant enough to warrant an increase in the stock price, despite the company's efforts to boost its balance sheet for AI data center growth.

Newcomers· Jul 29

Newcomers to the stock are focusing on the recent PIPE financing deal, with some seeing it as a bullish sign, while others are skeptical and concerned about the dilution of shares.
The stock's recent price and the fact that the financing was priced at $7.50, well above the current share price, are being discussed as significant developments for the company.
The CEO's track record and the company's history of generating little revenue and failing to achieve business goals are being questioned, with some investors expressing skepticism and concerns about the company's legitimacy.

Generated by AI

Meridian Bioscience

Social

Aug 17

Sentiment

Bullish· Jun 29

Bearish· Jun 18

Topics

Earnings· Jul 31

Announcements· Jun 29

Community

Regulars· Jul 29

Newcomers· Jul 29

Also Discussed

Meridian Bioscience Inc

Company Information

Location

Also Discussed

Social

Aug 17

Sentiment

Bullish· Jun 29

Bearish· Jun 18

Topics

Earnings· Jul 31

Announcements· Jun 29

Community

Regulars· Jul 29

Newcomers· Jul 29